Summary
GlobalData's new report, "Diabetes Care Devices Global Market Briefing to 2016" provides key data, information and analysis on the global diabetes care devices market. The report provides market landscape, competitive landscape and market trends information the diabetes care devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key segments covered include glucose monitoring devices (blood glucose test strips, blood glucose meters, lancets), and insulin delivery devices (insulin pens, insulin syringes, insulin pumps).
- Annualized global market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market drivers, and restraints by each category within diabetes care devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Roche, LifeScan, Novo Nordisk, Eli Lilly, Bayer, and Medtronic.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next being thing in the diabetes care devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global diabetes care devices market and the factors shaping it.
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Diabetes – An Overview 6
2.1 Epidemiology 6
3 Device Care Devices – An Overview 8
3.1 Glucose Monitoring Devices 8
3.2 Insulin Delivery Devices 9
4 Global Diabetes Care Devices: Market Characterization 10
4.1 Diabetes Care Devices Market, Global, Revenue ($bn), Historic, 2002-2009 10
4.2 Diabetes Care Devices Market, Global, Revenue ($bn), Forecast, 2009-2016 11
4.3 Glucose Monitoring Devices Market, Global, Revenue ($bn), Historic, 2002–2009 12
4.4 Glucose Monitoring Devices Market, Global, Volume (Units), Historic, 2002–2009 13
4.5 Glucose Monitoring Devices Market, Global, Revenue ($bn), Forecast, 2009–2016 14
4.6 Glucose Monitoring Devices Market, Global, Volume (Units), Forecast, 2009–2016 15
4.7 Insulin Delivery Devices Market, Global, Revenue ($bn), Historic, 2002–2009 16
4.8 Insulin Delivery Devices Market, Global, Volume (Units), Historic, 2002–2009 17
4.9 Insulin Delivery Devices Market, Global Revenue ($bn), Forecast, 2009-2016 18
4.10 Insulin Delivery Devices Market, Global, Volume (Units), Forecast, 2009–20016 19
4.11 Diabetes Care Devices, Market Drivers 20
4.11.1 Patient Convenience to be a
Major Factor in Choice of Diabetes Care Devices and will Drive the Market in the Near Future 20
4.11.2 Advances in the Technology and Introduction of New Generation Devices to Boost Sales of the Diabetes Care Devices 20
4.11.3 The Advantages Offered by Insulin Pumps to Niche Patient Groups is Expected to Drive the Insulin Pumps Market 21
4.11.4 Increasing Demand for Glucose Monitoring in Home Care to Drive Growth 21
4.12 Diabetes Care Devices, Market Restraints 21
4.12.1 Low Diagnosis Rate to Restrain Growth of Diabetes Care Devices Market 21
4.12.2 Cultural Preferences among the Elderly for Traditional Remedies may Negatively Effect Diabetes Care Devices Markets 21
4.12.3 Local Companies to Compete with Big Players in Terms of Distribution and Price 22
4.12.4 Regular Maintenance, Risk of Infection and Associated Pain Raise Patient Concerns about the Adoption of Diabetes Care Devices 22
4.12.5 Recent Product Recalls by the US Food and Drug Administration may Lead to Low Prescription Rates in the Future 22
4.12.6 High Cost to be a Major Deterrent towards Widespread Adoption of Insulin Pumps 23
5 US Diabetes Care Devices: Market Characterization 24
5.1 Diabetes Care Devices Market, US, Revenue ($m), Historic, 2002-2009 24
5.2 Diabetes Care Devices Market, US, Volume (units), Historic, 2002-2009 25
5.3 Diabetes Care Devices Market, US, Revenue ($m), Forecast, 2009-2016 26
5.4 Diabetes Care Devices Market, US, Volume (Units), Forecast, 2009-2016 27
6 Diabetes Care Devices Market, Competitive Assessment 28
6.1 Glucose Monitoring Devices Market, Global, Key Company Shares 29
6.2 Insulin Delivery Devices, Global, Key Company Shares 30
6.3 Diabetes Care Devices Market: Key Market Participants 31
6.3.1 F. Hoffmann-La Roche Ltd. 32
6.3.2 LifeScan, Inc. 33
6.3.3 Novo Nordisk A/S 34
6.3.4 Eli Lilly and Company 35
6.3.5 Bayer HealthCare AG 36
6.3.6 Medtronic, Inc. 37
7 Diabetes Care Devices Market, Pipeline Assessment 38
7.1 Diabetes Care Devices, Pipeline Products, by Segment 38
7.2 Profiles of Promising Diabetes Care Devices Under Clinical Development 39
7.2.1 Non Invasive Glucose Monitoring Devices 39
7.2.2 Insulin Pumps 40
7.2.3 Glucose Monitoring Devices 41
8 Appendix 44
8.1 Research Methodology 44
8.2 Secondary Research 45
8.3 Primary Research 45
8.4 Models 45
8.5 Forecasts 46
8.6 Expert Panels 46
8.7 GlobalData Consulting 46
8.8 Contact Us 46
8.9 Disclaimer 46
1.1 List of Tables
Table 1: Diabetes, Major Countries, Estimated Prevalence, 2010 and 2030 7
Table 2: Diabetes Care Devices Market, Global, Revenue ($bn), 2002–2009 10
Table 3: Diabetes Care Devices Market, Global, Revenue ($bn), 2009–2016 11
Table 4: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2002–2009 12
Table 5: Glucose Monitoring Devices Market, Global, Volume (million), 2002–2009 13
Table 6: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2009–2016 14
Table 7: Glucose Monitoring Devices Market, Global, Volume (million), 2009–2016 15
Table 8: Insulin Delivery Devices Market, Global, Revenue ($bn), 2002–2009 16
Table 9: Insulin Delivery Devices Market, Global, Volume (million), 2002–2009 17
Table 10: Insulin Delivery Devices Market, Global, Revenue ($bn), 2009–2016 18
Table 11: Insulin Delivery Devices Market, Global, Volume (million), 2009–2016 19
Table 12: Diabetes Care Devices Market US, Revenue ($m), 2002–2009 24
Table 13: Diabetes Care Devices Market, US, Volume (millions), 2002–2009 25
Table 14: Diabetes Care Devices Market, US, Revenue ($m), 2009–2016 26
Table 15: Diabetes Care Devices Market, US, Volume (Millions), 2009–2016 27
Table 16: Diabetes Care Devices Market, Global, Revenue ($m), 2009 28
Table 17: Glucose Monitoring Devices Market, Global, Revenue ($m), 2009 29
Table 18: Insulin Delivery Devices Market, Global, Revenue ($m), 2009 30
Table 19: Hoffmann-La Roche Ltd., Marketed Products, 2010 32
Table 20: Hoffmann-La Roche Ltd., Pipeline Products, 2010 32
Table 21: LifeScan, Inc. Marketed Products, 2010 33
Table 22: LifeScan, Inc. Pipeline Products, 2010 33
Table 23: Novo Nordisk A/S, Marketed Products, 2010 34
Table 24: Novo Nordisk A/S, Pipeline Products, 2010 34
Table 25: Eli Lilly and Company, Marketed Products, 2010 35
Table 26: Bayer HealthCare AG, Pipeline Products, 2010 36
Table 27: Medtronic, Inc. Marketed Products, 2010 37
Table 28: Medtronic, Inc. Pipeline Products, 2010 37
Table 29: Global Diabetes Care Devices Market, Pipeline, 2010 38
Table 30: EyeSense Blood Glucose Measurement Device, Product Status, 2010 39
Table 31: Easy Check Breathe Glucose Detection System, Product Status, 2010 39
Table 32: SENTRIS-100, Product Status, 2010 40
Table 33: Artificial Pancreas System, Product Status, 2010 40
Table 34: Disposable Insulin Pump System, Product Status, 2010 40
Table 35: Integrated Symbiq/EndoTool System, Product Status, 2010 41
Table 36: Paradigm Veo System, Product Status, 2010 41
Table 37: ACCU-Chek Inform II with RALS Plus Data Management System, Product Status, 2010 41
Table 38: Pin-SCAN-Non invasive Glucose Meter, Product Status, 2010 42
Table 39: Affinity-based Turbidity Sensor-Glucose Monitoring, Product Status, 2010 42
Table 40: RFID Glucose-Sensing Microchip, Product Status, 2010 42
Table 41: Silicon Micro-Needle, Product Status, 2010 43
1.2 List of Figures
Figure 1: Diabetes, Major Countries, Estimated Prevalence, 2010 and 2030 6
Figure 2: Diabetes Care Devices, Market Segments 8
Figure 3: Diabetes Care Devices Market, Global, Revenue ($bn), 2002–2009 10
Figure 4: Diabetes Care Devices Market, Global, Revenue ($bn), 2009–2016 11
Figure 5: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2002–2009 12
Figure 6: Glucose Monitoring Devices Market, Global, Volume (million), 2002–2009 13
Figure 7: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2009–2016 14
Figure 8: Glucose Monitoring Devices Market, Global, Volume (million), 2009–2016 15
Figure 9: Insulin Delivery Devices Market, Global, Revenue ($bn), 2002–2009 16
Figure 10: Insulin Delivery Devices Market, Global, Volume (million), 2002–2009 17
Figure 11: Insulin Delivery Devices Market, Global, Revenue ($bn), 2009–2016 18
Figure 12: Insulin Delivery Devices Market, Global, Volume (million), 2009–2016 19
Figure 13: Diabetes Care Devices Market US, Revenue ($m), 2002–2009 24
Figure 14: Diabetes Care Devices Market, US, Volume (millions), 2002–2009 25
Figure 15: Diabetes Care Devices Market, US, Revenue ($m), 2009–2016 26
Figure 16: Diabetes Care Devices Market, US, Volume (Millions), 2009–2016 27
Figure 17: Diabetes Care Devices Market, Global, Key Company Share, %, 2009 28
Figure 18: Glucose Monitoring Devices Market, Global, Key Company Share, %, 2009 29
Figure 19: Insulin Delivery Devices Market, Global, Key Company Share, %, 2009 30
Figure 20: Diabetes Care Devices Market, Presence of Key Market Participants by Segment, 2010 31
Figure 21: Global Diabetes Care Devices Market, Pipeline, 2010 38
Companies mentioned
F. Hoffmann-La Roche Ltd
LifeScan, Inc.
Novo Nordisk A/S
Eli Lilly and Company
Bayer HealthCare AG
Medtronic, Inc.